We are live on ! Find out more
SIOX

Sio Gene Therapies Inc. Common Stock
SIOX

Delisted

SIOX was delisted on the 22nd of March, 2023.

Back to rankings

1 hedge funds and large institutions have $26K invested in Sio Gene Therapies Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% less funds holding

Funds holding: 4 → 1 (-3)

98% less capital invested

Capital invested by funds: $1.13M → $26K (-$1.11M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
1
Holders Change
-3
Holders Change %
-75%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
JC
JBF Capital
Colorado
-$1.07M
2
CIA
Cladis Investment Advisory
Montana
-$32.3K
3
BBA
Baader Bank Aktiengesellschaft
Germany
-$4.53K
Name Holding Trade Value Shares
Change 		Change in
Stake
Macquarie Group
1
Macquarie Group
Australia
$26K – – –
JC
2
JBF Capital
Colorado
– -$1.07M -2,639,127 Closed
CIA
3
Cladis Investment Advisory
Montana
– -$32.3K -80,000 Closed
BBA
4
Baader Bank Aktiengesellschaft
Germany
– -$4.53K -14,000 Closed

SIOX Hedge Fund Activity: Q2 2023 in Review

1 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Sio Gene Therapies Inc. Common Stock (SIOX) for Q2 2023, worth a combined $26K — down 98% from $1.13M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of SIOX and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was JBF Capital, exiting entirely with an estimated $1.07M sold.

  • 1 institutional investor held Sio Gene Therapies Inc. Common Stock (SIOX) as of Q2 2023, down from 4 in Q1 2023.
  • Funds reported $26K of Sio Gene Therapies Inc. Common Stock stock for Q2 2023, down 98% quarter-over-quarter.
  • 0 funds opened new Sio Gene Therapies Inc. Common Stock positions in Q2 2023 and 3 closed out, a net change of -3 holders.
  • The largest Sio Gene Therapies Inc. Common Stock seller in Q2 2023 was JBF Capital, an estimated $1.07M sold.

Based on aggregated 13F filings for Q2 2023.